Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty (SLT): A Randomized, Masked, Placebo Controlled Study

NCT00485108 is registered in ClinicalTrials.gov with Queen's University as lead sponsor.

NCT NCT00485108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00485108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty (SLT): A Randomized, Masked, Placebo Controlled Study
Lead sponsor
Queen's University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2007
Completion date
December 31, 2014
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary open angle glaucoma, pseudoexfoliation glaucoma